HEMO

HEMO (China) Bioengineering Co., Ltd. is an international innovative medical enterprise primarily dedicated to the design, research and development, production, and sales of diagnostic and therapeutic solutions in the fields of neurovascular, peripheral vascular, and cardiovascular. With its operational headquarters in Beijing, the company aims to build a leading Chinese platform enterprise for vascular intervention innovations, providing comprehensive neurointervention solutions for cerebrovascular diseases such as ischemic stroke, hemorrhagic stroke, and intracranial vascular stenosis. Throughout the entire product lifecycle, HEMO strictly adheres to quality and safety standards to ensure the highest level of product reliability. HEMO China boasts a professional and experienced management and operations team, continuously developing world-leading innovative technology products through diversified R&D and international academic resources, with a strategic focus on key areas like neurointervention.